Summary
A 46-year-old man with adenocarcinoma of the sigmoid colon developed a hypersensitivity reaction after the sixth cycle of combination chemotherapy with oxaliplatin infusion. Hypersensitivity to oxaliplatin occurring, after several courses of therapy, in about 10–15% of patients, especially during or immediately after the oxaliplatin infusion. In this case report we present a delayed hypersensitivity reaction, consisting in dysesthesia and laryngeal spasm developed 10 h after the sixth administration of oxaliplatin.
References
Sarmiento R, Saponiero A, Gasparini G (2004) Therapeutic strategies to mprove the efficacy of oxaliplatin in gastrointestinal tumors. Int J Biol Markers 19:183–189
Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351. doi:10.1056/NEJMoa032709
Gowda A, Goel R, Berdzik J et al (2004) Hypersensitivity Reactions to oxaliplatin: incidence and management. Oncology 18:1671–1675
Edmondson DA, Gruling BJ, Urmanski AM et al (2007) Oxaliplatin hypersensitivity: case report and successful repeat desensitization. Am J Ther 14:116–118. doi:10.1097/01.pap. 0000249924.90645.5b
Maindrault-Goebel F, André T, Tournigand C et al (2005) Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients. Eur J Cancer 41:2262–1167. doi:10.1016/j.ejca.2005.06.021
de Vries RS, Mattijssen EJ, van Sorge AA (2006) Serious delayed hypersensitivity reaction to oxaliplatin. Ann Oncol 17:1723–1724. doi:10.1093/annonc/mdl116
Sorich J, Taubes B, Wagner A et al (2004) Oxaliplatin: practical guidelines for administration. Clin J Oncol Nurs 8:251–256. doi:10.1188/04.CJON.251-256
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s10637-010-9404-8
Rights and permissions
About this article
Cite this article
Potenza, S., Nasti, G., Alessandro, O. et al. Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction. Invest New Drugs 28, 185–186 (2010). https://doi.org/10.1007/s10637-009-9250-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-009-9250-8